Cargando…

Systemic lupus erythematosus and pulmonary arterial hypertension: links, risks, and management strategies

Systemic lupus erythematosus (SLE) is characterized by the second highest prevalence of pulmonary arterial hypertension (PAH), after systemic sclerosis, among the connective tissue diseases. SLE-associated PAH is hemodynamically defined by increased mean pulmonary artery pressure at rest (≥25 mmHg)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tselios, Konstantinos, Gladman, Dafna D, Urowitz, Murray B
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5191623/ https://www.ncbi.nlm.nih.gov/pubmed/28053559 http://dx.doi.org/10.2147/OARRR.S123549

Ejemplares similares

Gradual Glucocorticosteroid Withdrawal Is Safe in Clinically Quiescent Systemic Lupus Erythematosus
por: Tselios, Konstantinos, et al.
Publicado: (2021)

Importance of cumulative exposure to elevated cholesterol and blood pressure in development of atherosclerotic coronary artery disease in systemic lupus erythematosus: a prospective proof-of-concept cohort study
por: Nikpour, Mandana, et al.
Publicado: (2011)

Variability over time and correlates of cholesterol and blood pressure in systemic lupus erythematosus: a longitudinal cohort study
por: Nikpour, Mandana, et al.
Publicado: (2010)

Assessment of cardiovascular risk tools as predictors of cardiovascular disease events in systemic lupus erythematosus
por: Sivakumaran, Jagan, et al.
Publicado: (2021)

Utility of untimed single urine protein/creatinine ratio as a substitute for 24-h proteinuria for assessment of proteinuria in systemic lupus erythematosus
por: Medina-Rosas, Jorge, et al.
Publicado: (2015)

Prevalence and associated factors of resting electrocardiogram abnormalities among systemic lupus erythematosus patients without cardiovascular disease
por: Al Rayes, Hanan, et al.
Publicado: (2017)

The baseline interferon signature predicts disease severity over the subsequent 5 years in systemic lupus erythematosus
por: Mai, Lloyd, et al.
Publicado: (2021)

Development validation and reliability of the Systemic Lupus Erythematosus Disease Activity Index 2000 Responder Index-50
por: Touma, Z, et al.
Publicado: (2012)

Systemic Lupus Erythematosus and Pulmonary Hypertension
por: Parperis, Konstantinos, et al.
Publicado: (2023)

Baseline Characteristics and Risk Factors of Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus Patients
por: Huang, Can, et al.
Publicado: (2016)

The Role of Anti-Phosphatidylserine/Prothrombin Antibodies in Thrombotic Manifestations of Systemic Lupus Erythematosus Patients
por: Tselios, Konstantinos, et al.
Publicado: (2013)

Successful Management of Pregnancy in a Patient with Systemic Lupus Erythematosus-associated Pulmonary Arterial Hypertension
por: Kawabe, Akio, et al.
Publicado: (2018)

Asymptomatic Pulmonary Hypertension in Systemic Lupus Erythematosus
por: Kamel, Shereen R., et al.
Publicado: (2011)

Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus: Current Status and Future Direction
por: Dhala, Atiya
Publicado: (2012)

Risk assessment in systemic lupus erythematosus-associated pulmonary arterial hypertension: CSTAR-PAH cohort study
por: Wang, Qian, et al.
Publicado: (2022)

CBLN2 rs2217560 was Associated with Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus
por: Huang, Can, et al.
Publicado: (2018)

Pulse dose steroids in severe pulmonary arterial hypertension secondary to systemic lupus erythematosus
por: Lee, Cody, et al.
Publicado: (2017)

Validation of the REVEAL Prognostic Models in Systemic Lupus Erythematosus-Associated Pulmonary Arterial Hypertension
por: Qu, Jingge, et al.
Publicado: (2021)

Nonlymphoma hematological malignancies in systemic lupus erythematosus
por: Lu, M, et al.
Publicado: (2012)

Lung cancer in systemic lupus erythematosus
por: Kale, M, et al.
Publicado: (2012)

Frequency and predictors of pulmonary hypertension in patients with Systemic Lupus Erythematosus
por: Asif, Sadia, et al.
Publicado: (2019)

Safety and efficacy of hCDR1 (Edratide) in patients with active systemic lupus erythematosus: results of phase II study
por: Urowitz, Murray B, et al.
Publicado: (2015)

Successful pregnancy in pulmonary arterial hypertension associated with systemic lupus erythematosus: a case report
por: Streit, Michael, et al.
Publicado: (2009)

Characteristics of exercise capacity in female systemic lupus erythematosus associated pulmonary arterial hypertension patients
por: Pudasaini, Bigyan, et al.
Publicado: (2018)

The Role of Conjunctival Microvasculation Combined with Echocardiography in Evaluating Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus
por: Xiong, Jiangbiao, et al.
Publicado: (2021)

Anesthetic management of cesarean delivery of parturient with systemic lupus erythematosus associated with pulmonary arterial hypertension - A case report -
por: Lertkovit, Saranya, et al.
Publicado: (2022)

Influenza A/H1N1 septic shock in a patient with systemic lupus erythematosus. A case report
por: Tselios, Konstantinos, et al.
Publicado: (2011)

Lupus and the Lungs: The Assessment and Management of Pulmonary Manifestations of Systemic Lupus Erythematosus
por: Amarnani, Raj, et al.
Publicado: (2021)

Sjögren’s syndrome and systemic lupus erythematosus: links and risks
por: Pasoto, Sandra Gofinet, et al.
Publicado: (2019)

Identification and Validation of a Urinary Biomarker Panel to Accurately Diagnose and Predict Response to Therapy in Lupus Nephritis
por: Whittall-Garcia, Laura, et al.
Publicado: (2022)

Pulmonary hypertension in systemic lupus erythematosus: an independent predictor of patient survival
por: Min, Hong Ki, et al.
Publicado: (2015)

Efficacy of immunosuppressants with bridge vasodilator therapy in severe lupus erythematosus‐associated pulmonary arterial hypertension
por: Sanges, Sébastien, et al.
Publicado: (2019)

Clinical characteristics and prognosis in systemic lupus erythematosus-associated pulmonary arterial hypertension based on consensus clustering and risk prediction model
por: Dai, Mengmeng, et al.
Publicado: (2023)

Evaluation of serum uric acid level in systemic lupus erythematosus patients with normal and high pulmonary arterial hypertension
por: Aghdashi, Miramir, et al.
Publicado: (2018)

Impact of pregnancy in patients with systemic lupus erythematosus-associated pulmonary arterial hypertension: case series and literature review
por: Li, Mucong, et al.
Publicado: (2022)

The diagnostic and prognostic value of growth differentiation factor‐15 in systemic lupus erythematosus‐associated pulmonary arterial hypertension
por: Qian, Junyan, et al.
Publicado: (2023)

A prognostic model for systemic lupus erythematosus-associated pulmonary arterial hypertension: CSTAR-PAH cohort study
por: Qu, Jingge, et al.
Publicado: (2023)

Rationale and design of the screening of pulmonary hypertension in systemic lupus erythematosus (SOPHIE) study
por: Huang, Duo, et al.
Publicado: (2018)

Systemic Sclerosis and Systemic Lupus Erythematosus Overlap Syndrome with Pulmonary Arterial Hypertension Successfully Treated with Immunosuppressive Therapy and Riociguat
por: Kuzuya, Kentaro, et al.
Publicado: (2019)

Pulmonary Arterial Hypertension (PAH) as the Initial Manifestation of Systematic Lupus Erythematosus (SLE): A Rare Presentation
por: Kamath, Sangita D, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8nk29pgbgpe84bdukugs4cqaav